Turkey's Central Bank Raises Key Interest Rate to 25%
By Ed Frankl
Turkey's central bank on Thursday raised its key interest rate for the third consecutive meeting, as it attempts to wrest back control of climbing inflation in the troubled economy.
The bank raised the country's benchmark interest rate, the one-week repo rate, to 25% from 17.5%. After a series of cuts, the bank increased rates in June for the first time since 2021.
The hike compares with expectations of a key rate of 20%, according to a consensus of economists polled by FactSet. Some analysts have called on the bank to take aggressive action to tamp down on inflation, which jumped to 48% on year in July from 38% in June.
The Turkish lira has also fallen more than 30% against the dollar since the start of the year.
The decision is the latest by the country's new central-bank governor, Hafize Gaye Erkan, a former executive of First Republic Bank and Goldman Sachs, who was appointed after President Recep Tayyip Erdogan won a close-fought re-election, in what many saw as a return to more orthodox monetary policy.
Write to Ed Frankl at edward.frankl@wsj.com
(END) Dow Jones Newswires
August 24, 2023 07:27 ET (11:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software